Share chart Dyne Therapeutics, Inc.
Extended chart
Simple chart
About Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc., компания, занимающаяся заболеваниями мышц, работает как биотехнологическая компания, которая занимается продвижением терапевтических средств для лечения генетически обусловленных заболеваний мышц в Соединенных Штатах. Он разрабатывает различные программы для миотонической дистрофии 1 типа, мышечной дистрофии Дюшенна и фациоскапуло-плечевой дистрофии, а также для лечения редких заболеваний скелетных мышц, сердечных и метаболических мышц, используя платформу FORCE, которая обеспечивает терапию, изменяющую заболевание. more details| IPO date | 2020-09-17 |
|---|---|
| ISIN | US26818M1080 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.dyne-tx.com |
| Цена ао | 15.5 |
| Change price per day: | +0.2191% (13.69) |
|---|---|
| Change price per week: | -2.9% (14.13) |
| Change price per month: | -42.76% (23.97) |
| Change price per 3 month: | -55.35% (30.73) |
| Change price per half year: | -67.99% (42.86) |
| Change price per year: | -35.16% (21.16) |
| Change price per 3 year: | +94.61% (7.05) |
| Change price per 5 year: | 0% (13.72) |
| Change price per 10 year: | 0% (13.72) |
| Change price per year to date: | -42.76% (23.97) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8 | 9.18 |
| Fcpm III Services B.v. | 8 | 8.98 |
| Blackrock Inc. | 5 | 6.17 |
| Deep Track Capital, LP | 5 | 5.21 |
| Citadel Advisors Llc | 4 | 4.87 |
| State Street Corporation | 4 | 4.8 |
| Mpm Asset Management, LLC | 3 | 3.95 |
| Vanguard Group Inc | 3 | 3.94 |
| FMR, LLC | 3 | 3.68 |
| RTW Investments LP | 3 | 3.54 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Dr. Romesh Subramanian Ph.D. | Co-Founder & Advisor | 565.17k | 1965 (60 years) |
| Dr. Oxana Beskrovnaya Ph.D. | Chief Scientific Officer | 631.08k | 1961 (64 years) |
| Ms. Amy Reilly | Senior VP and Head of Corporate Communications & Investor Relations | N/A | 1974 (51 year) |
| Ms. Debra Feldman | Chief Regulatory Affairs Officer | N/A | 1971 (54 years) |
| Mr. Richard William Scalzo M.B.A. | Senior VP and Head of Finance & Administration | N/A | 1986 (39 years) |
| Mr. Daniel Wilson | Senior VP & Head of Legal | N/A | 1972 (53 years) |
| Mr. John Najim M.B.A. | Chief Technical Officer | N/A | |
| Mr. John G. Cox M.B.A. | CEO, President & Director | 1963 (62 years) | |
| Ms. Lucia Celona | Chief Human Resource Officer | 1966 (59 years) | |
| Dr. Ashish Dugar M.B.A., Ph.D. | Chief Medical Affairs Officer |
Address: United States, Waltham, MA , 830 Winter Street - open in Google maps, open in Yandex maps
Website: https://www.dyne-tx.com
Website: https://www.dyne-tx.com
